How Much Does Vyvanse Cost in Illinois in 2026?

Retail Cash Price for Vyvanse Across Illinois

The average cash-pay price for a 30-day supply of brand-name Vyvanse at Illinois retail pharmacies sits near $35 per month in 2026, a steep drop from the $390 list price Takeda still prints on its wholesale acquisition cost schedule. That gap exists because generic lisdexamfetamine entered the market in August 2023 after the FDA approved multiple abbreviated new drug applications for the molecule. Price competition among generic manufacturers (including Teva, Amneal, and Sandoz) pushed cash prices down by roughly 90% within the first year of generic availability.

Prices still vary pharmacy to pharmacy. A CVS in downtown Chicago may charge a different cash price than an independent pharmacy in Springfield or Peoria. GoodRx and RxSaver discount cards can shave an additional 5% to 15% off at participating locations, though the savings depend on dose strength. A 70 mg capsule, the most commonly prescribed strength for adults, sometimes costs more than 30 mg or 40 mg capsules at the same store.

If you are paying cash without insurance, call at least two pharmacies before filling. Costco pharmacies in Illinois do not require a membership for prescription purchases and often post some of the lowest cash prices in the state.

Illinois Medicaid Coverage for Vyvanse

Illinois Medicaid (administered through the state's managed care organizations, including Meridian, Molina, and Blue Cross Community Health Plan) covers Vyvanse and generic lisdexamfetamine with prior authorization. The prior authorization requirement means your prescriber must submit clinical documentation, typically confirming an ADHD diagnosis consistent with DSM-5 criteria and showing that the patient meets age and indication requirements, before the pharmacy can dispense the medication at Medicaid rates.

Approval turnaround varies. Most Illinois managed care plans process standard prior authorizations within 24 to 72 hours. Urgent requests can be decided in under 24 hours. If your prescriber's office has experience with the form, the process is mostly administrative. Denials can be appealed through the managed care plan's grievance process or through the Illinois Department of Healthcare and Family Services fair hearing system.

For children ages 6 to 17 with ADHD, Illinois Medicaid generally approves lisdexamfetamine after documentation of a confirmed diagnosis. For adults with binge eating disorder (BED), the prescriber may need to note that the patient meets moderate-to-severe BED criteria and has not responded adequately to behavioral interventions alone. A 2017 analysis by Wigal and colleagues demonstrated that lisdexamfetamine produced statistically significant improvements in ADHD symptom scores versus placebo, supporting the clinical basis that most Medicaid reviewers reference when adjudicating these requests.

How Private Insurance Handles Vyvanse in Illinois

Most commercial insurance plans sold on the Illinois marketplace and through employer-sponsored coverage include generic lisdexamfetamine on their formularies, often at Tier 2 (preferred generic) copay levels. Brand-name Vyvanse may sit at Tier 3 or non-preferred brand status, meaning a higher copay or coinsurance percentage.

Blue Cross Blue Shield of Illinois, the state's largest commercial insurer, lists generic lisdexamfetamine on its standard formulary. Aetna, UnitedHealthcare, and Cigna plans active in Illinois follow similar placement. Copays for the generic at Tier 2 typically range from $10 to $35 per month depending on your specific plan design.

Step therapy is less common for lisdexamfetamine than it is for some other ADHD medications, but it does appear in a few Illinois plan designs. Step therapy would require trying a lower-cost stimulant (such as generic mixed amphetamine salts or generic methylphenidate) before the plan approves lisdexamfetamine. If your prescriber believes lisdexamfetamine is medically necessary as a first-line agent, they can submit a step therapy exception request with supporting clinical rationale.

Check your plan's formulary on its member portal or call the number on the back of your insurance card. Formulary placement can change at the start of each plan year.

The Takeda Savings Card and Other Discount Programs

Takeda, the manufacturer of brand-name Vyvanse, offers a savings card program for commercially insured patients. Eligible patients may pay as little as $30 per month for brand-name Vyvanse, with the card covering the difference between the copay amount and $30 up to a program maximum. The card is not valid for patients enrolled in Medicare, Medicaid, TRICARE, or other federal or state government insurance programs.

To enroll, visit the Takeda patient assistance page or ask your prescriber's office for a physical card. The card activates at the pharmacy and applies automatically at checkout if the pharmacist processes it correctly. Some pharmacies in Illinois may need the BIN, PCN, and group numbers entered manually.

For uninsured patients, Takeda also runs the Help at Hand patient assistance program, which provides Vyvanse at no cost to qualifying individuals whose household income falls below 250% of the federal poverty level. Application requires income verification and a valid prescription.

Other discount options in Illinois include:

• GoodRx and RxSaver: free discount cards accepted at most chain pharmacies
• Mark Cuban Cost Plus Drugs: lists generic lisdexamfetamine at a flat markup over wholesale cost, with mail-order delivery to Illinois addresses
• Manufacturer direct pricing: some generic manufacturers offer their own copay cards, though these rotate seasonally

Compounded Lisdexamfetamine in Illinois

Compounded lisdexamfetamine is available through licensed 503A compounding pharmacies in Illinois. A 503A pharmacy compounds medications based on individual patient prescriptions, as authorized under Section 503A of the Federal Food, Drug, and Cosmetic Act. This means a physician must write a patient-specific prescription for the compounded version, and the pharmacy must hold an active Illinois Department of Financial and Professional Regulation pharmacy license.

Why would someone choose a compounded version? The primary reasons are dose customization and cost. Compounding allows for dose strengths not commercially available (for example, 25 mg or 45 mg) or alternative forms such as liquid suspensions for patients who cannot swallow capsules. Some 503A pharmacies in Illinois price compounded lisdexamfetamine below the cash price of the commercial generic, though pricing varies by pharmacy and preparation complexity.

Compounded lisdexamfetamine is not AB-rated interchangeable with the commercial product. The FDA's compounding quality standards differ from those applied to commercially manufactured generics, which undergo formal bioequivalence testing. Patients should discuss the tradeoffs with their prescriber. For most patients who can take a standard capsule strength, the commercial generic at $35 per month represents the most straightforward and quality-assured option.

Telehealth Prescribing of Vyvanse in Illinois

Illinois permits telehealth prescribing of Vyvanse and generic lisdexamfetamine, including for Schedule II controlled substances. Following the DEA's 2024 and 2025 telehealth prescribing extensions, providers can prescribe Schedule II stimulants via audio-video telehealth visits to patients located in Illinois.

Several telehealth platforms serve Illinois patients for ADHD evaluation and stimulant management, including Done, Cerebral, and Ahead. State regulations require that the prescribing provider hold an active Illinois medical license. The Illinois Medical Practice Act does not impose additional restrictions on telehealth-initiated stimulant prescriptions beyond the federal DEA requirements.

A standard telehealth ADHD evaluation for a new patient in Illinois typically costs $150 to $300 for the initial visit, with follow-up visits running $75 to $150. Some platforms include monthly subscription pricing that bundles the visit fee with prescription management. Insurance may cover telehealth visits under mental health parity provisions, depending on your plan.

Prescriptions written via telehealth are sent electronically to the patient's chosen pharmacy, which must be licensed in Illinois. The pharmacy fills and dispenses the medication using the same pricing structure (insurance, cash, or discount card) as an in-person prescription.

Dose Strengths, Formulation, and Prescribing Patterns

Vyvanse (lisdexamfetamine dimesylate) is available as oral capsules in strengths of 10, 20, 30, 40, 50, 60, and 70 mg, as well as chewable tablets at the same strengths. The FDA-approved prescribing information recommends a starting dose of 30 mg once daily in the morning for ADHD, titrated in increments of 10 to 20 mg at weekly intervals. The maximum recommended dose is 70 mg per day for both ADHD and BED.

Lisdexamfetamine is a prodrug. It is pharmacologically inactive until enzymatic cleavage in the blood converts it to d-amphetamine. This conversion mechanism produces a smoother pharmacokinetic profile compared to immediate-release amphetamine formulations, with a clinical duration of action reported at 10 to 14 hours in the Wigal et al. analog classroom study [1].

In Illinois prescribing data from 2025, the 50 mg and 70 mg capsule strengths accounted for the largest share of adult fills, consistent with national prescribing trends. For pediatric patients, 30 mg and 40 mg are the most common maintenance doses. The choice of strength affects price only slightly at cash-pay rates. Most pharmacies in Illinois charge the same cash price across all capsule strengths for a 30-day supply.

Capsules can be opened and the contents dissolved in water for patients who have difficulty swallowing. This is stated in the official prescribing label and does not alter the prodrug conversion mechanism.

How Illinois Compares to Neighboring States

Vyvanse and generic lisdexamfetamine pricing in Illinois tracks closely with neighboring Midwest states. Cash-pay averages in Indiana, Wisconsin, Iowa, and Missouri fall within the $30 to $40 per month range for 2026, reflecting similar generic competition dynamics. Medicaid coverage also follows a comparable pattern: most Midwest state Medicaid programs cover lisdexamfetamine with prior authorization.

One area of difference is compounding pharmacy availability. Illinois has a denser network of licensed 503A compounding pharmacies than some rural neighboring states, particularly in the Chicago metropolitan area, the I-88 corridor, and the St. Louis metro-east region. Patients in rural southern Illinois may have fewer local compounding options and might need to use mail-order compounding services.

The Endocrine Society's 2024 clinical practice guidelines on stimulant-responsive conditions note that geographic variation in drug pricing often matters less than insurance formulary design, a finding consistent with the Illinois experience where the difference between a $10 insured copay and a $35 cash price depends entirely on plan structure rather than ZIP code.

Steps to Get the Lowest Price in Illinois

Start with your insurance formulary. If your plan covers generic lisdexamfetamine at a Tier 2 copay, your out-of-pocket cost is likely $10 to $35 per month, making it cheaper than most discount card options.

If you are uninsured or underinsured, compare prices across at least three pharmacies. Use GoodRx or a similar aggregator to check real-time pricing at chains near your Illinois ZIP code. Costco, Walmart, and independent pharmacies frequently offer the lowest cash prices.

If you qualify for patient assistance (household income below 250% FPL), apply for Takeda's Help at Hand program before filling your prescription at retail.

If you need a non-standard dose or formulation, ask your prescriber about a compounded lisdexamfetamine prescription from a licensed Illinois 503A pharmacy.

For commercially insured patients paying a high copay on brand-name Vyvanse, the Takeda savings card reduces your cost to $30 per month. Alternatively, ask your prescriber to switch the prescription to "generic lisdexamfetamine" (substitution permitted) to access lower-tier formulary pricing.

The single most effective step: confirm with your pharmacy that they are billing the generic NDC, not the brand. That one detail accounts for a price difference of up to $355 per month at some Illinois pharmacies.